(Q40552744)

21 September 2017

1 reference

title

The P blood group system: biochemical, serological, and clinical aspects (English)

1 reference

21 September 2017

Spitalnik PF

1

1 reference

21 September 2017

Spitalnik SL

series ordinal

2

1 reference

21 September 2017

language of work or name

1 reference

1 April 1995

1 reference

Transfusion Medicine Reviews

21 September 2017

published in

1 reference

21 September 2017

volume

9

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

110-122

1 reference

Philip Levine Award Lecture: Blood Group Glycolipid Antigens and Their Modifications as Human Cancer Antigens

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Further Observations on Individual Differences of Human Blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Isoimmunization by a new blood factor in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Blood Group P Substance in Hydatid Cyst Fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The alpha-galactose specificity of anti-Pk

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The nature of the human blood group P1 determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Structure of the human erythrocyte blood group P1 glycosphingolipid

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Human erythrocyte P and Pk blood group antigens: identification as glycosphingolipids

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The glycosphingolipid composition of the placenta of a blood group P fetus delivered by a blood group Pk1 woman and analysis of the anti-globoside antibodies found in maternal serum

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Verotoxin receptor glycolipid in human renal tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Glycosphingolipids of human peripheral nervous system myelins isolated from cauda equina

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Glycolipid expression in prostatic tissue and analysis of the antigen recognized by antiprostatic monoclonal antibody APG1

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Neutral glycolipids of human and bovine milk

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Studies on the biosynthetic pathway of human P erythrocyte antigens using somatic cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Presence of P blood group antigens on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

A murine monoclonal IgM antibody specific for blood group P antigen (globoside)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Expression of red cell antigens by K562 human leukemia cells before and after induction of hemoglobin synthesis by hemin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The glycosphingolipid composition of the human hepatoma cell line,Hep-G2

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Human teratocarcinoma stem cells: glycolipid antigen expression and modulation during differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Structural characterization of x2 glycosphingolipid, its extended form, and its sialosyl derivatives: accumulation associated with the rare blood group p phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Serological and immunochemical characterization of anti-PP1Pk (anti-Tja) antibodies in blood group little p individuals. Blood group A type 4 recognition due to internal binding

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Red Cell Antigens P (Globoside) and Luke: Identification by Monoclonal Antibodies Defining the Murine Stage-Specific Embryonic Antigens -3 and -4 (SSEA-3 and SSEA-4)

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Possible role of ceramide in defining structure and function of membrane glycolipids

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Association of glycosphingolipids with intermediate filaments of human umbilical vein endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Solution conformation of Forssman antigen probed by NOE and exchange interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Glycosphingolipid backbone conformation and behavior in cholesterol-containing phospholipid bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Studies on the Biosynthetic Pathway of Human P Erythrocyte Antigen using Genetic Complementation Tests between Fibroblasts from Rare p and PkPhenotype Donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Defects of glycosyltransferase activities in human fibroblasts of Pk and p blood group phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Identification of UDP-galactose: lactose (lactosylceramide) alpha-4 and beta-3 galactosyltransferases in human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Biosynthesis of the blood group Pk and P1 antigens by human kidney microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Studies on the human blood group P system: an existence of UDP-Gal:lactosylceramide alpha 1----4 galactosyltransferase in the small p type cells

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

In vitro biosynthesis of GbOse4Cer (globoside) and GM2 ganglioside by the (1 → 3) and (1 → 4)-N-acetyl β-d-galactosaminyltransferases from embryonic chicken brain. Solubilization, purification, and characterization of the transferases

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Biosynthesis of the blood group P antigen-like GalNAc beta 1-->3Gal beta 1-->4GlcNAc/Glc structure: a novel N-acetylgalactosaminyltransferase in human blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Chemical synthesis of the human blood-group P1-anti-genic determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Synthesis of spacer-arm, lipid, and ethyl glycosides of the terminal trisaccharide [alpha-D-Gal-(1----4)-beta-D-Gal-(1----4)-beta-D-GlcNAc] portion of the blood-group P1 antigen: preparation of neoglycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Synthesis of disaccharide analogues of methyl 4-O-alpha-D-galactopyranosyl-beta-D-galactopyranoside ("methyl urobioside"), the minimum structure recognized by p-fimbriated E. coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Synthetic receptor analogues: the conformation of methyl 4-O-α-d-galactopyranosyl-β-d-galactopyranoside (methyl β-d-galabioside) and related derivatives, determined by N.M.R. and computational methods

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Genetic genealogical studies of 20 north Swedish families with the rare blood group p

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Report of the Committee on the Genetic Constitution of Chromosomes 20, 21, and 22

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Comparative automated assay of anti-P1 antibodies in acute hepatic distomiasis (fascioliasis) and in hydatidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

An apparent primary immune response involving anti-Jka and anti-P1 detected 10 days after transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Avian P1 antigens inhibit agglutination mediated by P fimbriae of uropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Allo-anti-P1 in a P1-positive person

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

AN AGGLUTININ ASSOCIATED WITH THE P AND THE ABO BLOOD GROUP SYSTEMS

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

LKE red cell antigen and its relationship to P1 and Pk: serological study of a large family

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Anti-LKE in a pregnant woman

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Autoagglutinins with apparent anti-P specificity reactive only by low-ionic-strength salt techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Auto-anti-P reacting only by low-ionic-strength solutions in a patient with hemolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Paroxysmal cold haemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Cytotoxicity of anti-PP1Pk antibodies and possible relationship with early abortions of p mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The association of anti-P and early abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Early treatment by plasmapheresis in a woman with multiple abortions and the rare blood group p.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

A new therapeutic antibody removal method using antigen-positive red cells. II. Application to a P-incompatible pregnant woman

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Removal of maternal antibodies from a woman with repeated fetal loss due to P blood group incompatibility

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Neutralization of P blood group antibodies by synthetic solid-phase antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Use of isotope-labelled red cells to demonstrate incompatibility in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Crossmatch compatible blood for patients with anti-P1.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Report of transfusions of M- and P1-positive red cells to a patient with anti-M and anti-P1.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Delayed hemolytic transfusion reaction caused by anti-P1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Delayed hemolytic transfusion reaction caused by anti‐P1

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The manual polybrene test: a simple and rapid procedure for detection of red cell antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Lack of clinical significance of "enzyme-only" red cell alloantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Characterization of a murine monoclonal antibody specific for the human P1 blood group antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal alpha 1-4Gal beta 1-4Glc beta-O and Gal alpha 1-4Gal beta 1-4GlcNAc beta-O residues: useful immunochemical and cytochemical reagents for blood group P antigens [...]

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Serological characterisation of a mouse monoclonal anti-P-like antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

A monoclonal antibody against a Burkitt lymphoma associated antigen has an anti-Pkred blood cell specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Southwestern Internal Medicine Conference: Shiga-like toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages fromEscherichia coli933

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: differential basis of phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Enzyme-linked immunosorbent assay for Shiga toxin and Shiga-like toxin II using P1 glycoprotein from hydatid cysts.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Investigation of Shiga-like Toxin Binding to Chemically Synthesized Oligosaccharide Sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Glycolipid modification of α2 interferon binding. Sequence similarity between the α2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

CD77: an antigen of germinal center B cells entering apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Comparison of the B-pentamers of heat-labile enterotoxin and verotoxin-1: two structures with remarkable similarity and dissimilarity.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Paroxysmal Cold Hemoglobinuria in a Patient withKlebsiella pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

An unusual Donath-Landsteiner antibody detectable at 37 degrees C by the antiglobulin test

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Transient Donath-Landsteiner haemolytic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Biphasic hemolysin hemolytic anemia: reappraisal of an acute immune hemolytic anemia of infancy and childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

A Remarkable Family with the Rare Human Isoantibody Anti-Tj a in Four Siblings: Anti-Tj a and Habitual Abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The rare human isoagglutinin anti-Tja and habitual abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Animal glycosphingolipids as membrane attachment sites for bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Occurrence of P-fimbriated Escherichia coli in urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

pap-2-encoded fimbriae adhere to the P blood group-related glycosphingolipid stage-specific embryonic antigen 4 in the human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The receptor repertoire defines the host range for attaching Escherichia coli strains that recognize globo-A.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Virulence factors in Escherichia coli urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

P-fimbriae of pyelonephritogenic Escherichia coli: significance for reflux and renal scarring-a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Influence of blood group on the availability of receptors for attachment of uropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Overrepresentation of blood group non-secretors in adults with renal scarring

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

The K88 fimbrial adhesin of enterotoxigenic Escherichia coli binds to beta 1-linked galactosyl residues in glycosphingolipids

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

A simple reliable agglutination test for screening P-fimbriated Escherichia coli in children with urinary tract infections gives valuable clinical information

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Bacterial and host determinants of renal scarring

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Virulence-associated traits in Escherichia coli causing first and recurrent episodes of urinary tract infection in children with or without vesicoureteral reflux

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

P blood group and proneness to urinary tract infection in Japanese children

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Urinary tract infections and P blood group antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Recurrent bacteriuria and primary biliary cirrhosis: ABO blood group, P1 blood group, and secretor status

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Lack of correlation of P blood group phenotype and renal scarring

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Human parvoviruses: implications for transfusion medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

A human parvovirus-like virus inhibits haematopoietic colony formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Erythrocyte P antigen: cellular receptor for B19 parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2805%2980050-1

7 January 2021

10.1016/S0887-7963(05)80050-1

Identifiers

DOI

1 reference

21 September 2017

1 reference